T1	Participants 72 92	patients with asthma
T2	Participants 292 327	patients with a diagnosis of asthma
T3	Participants 329 474	Adult asthma patients undergoing treatment with budesonide 400 microg b.i.d. and salbutamol 200 microg p.r.n. less than twice weekly were studied
T4	Participants 1358 1378	patients with asthma
